Phase III Randomized, Double-Blind Clinical Trial to Determine the Role of Magnesium Sulfate in Adductor Canal Block in Total Knee Arthroplasty

Status

Not yet recruiting

Phases

Phase 3

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-518601-17-00

Acronym

FPS-SMG-2021-02

Enrollment

131

Registered

2024-10-14

Start date

Unknown

Completion date

Unknown

Last updated

2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total knee arthroplasty

Brief summary

Time in minutes elapsed from when the patient receives the adductor canal block until the first request for rescue analgesia.

Interventions

DRUGMAGNESIUM SULFATE

DRUGROPIVACAINE HYDROCHLORIDE

DRUGSALINE

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
Time in minutes elapsed from when the patient receives the adductor canal block until the first request for rescue analgesia.	—

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026